AIRLINK 78.39 Increased By ▲ 5.39 (7.38%)
BOP 5.32 Decreased By ▼ -0.03 (-0.56%)
CNERGY 4.28 Decreased By ▼ -0.03 (-0.7%)
DFML 30.87 Increased By ▲ 2.32 (8.13%)
DGKC 78.00 Increased By ▲ 3.71 (4.99%)
FCCL 20.57 Increased By ▲ 0.22 (1.08%)
FFBL 32.00 Increased By ▲ 1.10 (3.56%)
FFL 10.20 Increased By ▲ 0.14 (1.39%)
GGL 10.29 Decreased By ▼ -0.10 (-0.96%)
HBL 118.60 Increased By ▲ 2.63 (2.27%)
HUBC 135.80 Increased By ▲ 3.60 (2.72%)
HUMNL 6.75 Increased By ▲ 0.07 (1.05%)
KEL 4.17 Increased By ▲ 0.14 (3.47%)
KOSM 4.80 Increased By ▲ 0.20 (4.35%)
MLCF 39.00 Increased By ▲ 0.46 (1.19%)
OGDC 134.30 Increased By ▲ 0.45 (0.34%)
PAEL 23.45 Decreased By ▼ -0.38 (-1.59%)
PIAA 27.05 Decreased By ▼ -0.08 (-0.29%)
PIBTL 7.00 Increased By ▲ 0.24 (3.55%)
PPL 113.25 Increased By ▲ 0.45 (0.4%)
PRL 27.68 Decreased By ▼ -0.48 (-1.7%)
PTC 14.65 Decreased By ▼ -0.24 (-1.61%)
SEARL 56.60 Increased By ▲ 0.18 (0.32%)
SNGP 65.99 Increased By ▲ 0.19 (0.29%)
SSGC 11.03 Increased By ▲ 0.02 (0.18%)
TELE 9.12 Increased By ▲ 0.10 (1.11%)
TPLP 11.83 Decreased By ▼ -0.07 (-0.59%)
TRG 70.94 Increased By ▲ 1.84 (2.66%)
UNITY 24.05 Increased By ▲ 0.34 (1.43%)
WTL 1.33 No Change ▼ 0.00 (0%)
BR100 7,503 Increased By 68.8 (0.93%)
BR30 24,584 Increased By 364.4 (1.5%)
KSE100 72,108 Increased By 748.8 (1.05%)
KSE30 23,833 Increased By 266.1 (1.13%)
World

South Korea to begin COVID-19 vaccinations for general public in Q3

  • Inoculations would begin in February starting with key groups, including medical workers and the elderly in nursing homes, Jeong said.
Published January 28, 2021

SEOUL: South Korea said on Thursday it would begin COVID-19 vaccinations for the general public in the third quarter of this year, the Korea Disease Control and Prevention Agency (KDCA) director Jeong Eun-kyeong told a news briefing.

Inoculations would begin in February starting with key groups, including medical workers and the elderly in nursing homes, Jeong said.

The country said it aimed to reach "herd immunity" levels through mass vaccinations by November.

Comments

Comments are closed.